Resistant TB: Newer Drugs and Community Approach

Publisher： Bentham Science Publishers

E-ISSN： 2212-4071|6|1|27-37

ISSN： 1574-891X

Source： Recent Patents on Anti-Infective Drug Discovery, Vol.6, Iss.1, 2011-01, pp. : 27-37

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the Human Macrophage with Combinations of Drugs and Inhibitors of Ca2+ and K+ Transport to Enhance the Killing of Intracellular Multi-Drug Resistant Mycobacterium tuberculosis (MDR-TB) - a Novel, Patentable Approach to Limit the Emergence of XDR-TB

By  

Recent Patents on Anti-Infective Drug Discovery, Vol. 6, Iss. 2, 2011-05 ,pp. : 110-117

Bentham Science Publishers

Access to resources Recommend Favorite

Current Approaches for New TB Drugs

By  

Current Respiratory Medicine Reviews, Vol. 10, Iss. 2, 2014-06 ,pp. : 88-96

Bentham Science Publishers

Access to resources Recommend Favorite

Current Approaches for New TB Drugs

By  

Current Respiratory Medicine Reviews, Vol. 10, Iss. 2, 2014-11 ,pp. : 88-96

Bentham Science Publishers

Access to resources Recommend Favorite

Reversal of Newer Direct Oral Anticoagulant Drugs (DOACs)

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 14, Iss. 2, 2017-01 ,pp. : 76-81

Bentham Science Publishers

Access to resources Recommend Favorite

Preclinical Study of New TB Drugs and Drug Combinations in Mouse Models

By  

Recent Patents on Anti-Infective Drug Discovery, Vol. 3, Iss. 2, 2008-06 ,pp. : 102-116

Bentham Science Publishers

Access to resources Recommend Favorite